Skip to content

Clinical research on the application of Guizhi Fuling Capsules in the treatment of postpartum period

Clinical research on the application of Guizhi Fuling Capsules in the treatment of postpartum period

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119886
Enrollment
Unknown
Registered
2026-03-04
Start date
2022-06-19
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Puerperal rehabilitation

Interventions

Experimental group:On the basis of conventional western medicine treatment, he was given oral Guizhi Tuckahoe capsule
Control group:The basis of conventional western medicine treatment

Sponsors

The Third Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. First-time mother; 2. Age between 18 and 35 years old; 3. Vaginal delivery at full term; 4. Agree to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Those with postpartum hemorrhage; 2. Those with placental adhesion and implantation; 3. Those with reproductive tract tumors such as uterine fibroids; 4. Those with acute reproductive tract inflammation; 5. Those with severe primary diseases such as cardiovascular, liver, kidney and blood system disorders; 6. Those with allergic constitution and those allergic to the ingredients of this preparation; 7. Those with uterine malformations such as uterine septum.

Design outcomes

Primary

MeasureTime frame
Involution of uterus;Lochia;

Secondary

MeasureTime frame
The incidence of urinary retention;Constipation;

Countries

China

Contacts

Public ContactLingling Wu

The Third Affiliated Hospital, Sun Yat-sen University

wulling@mail.sysu.edu.cn+86 20 8217 9685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026